Self-Management for Amputee Rehabilitation Using Technology.
Launched by UNIVERSITY OF BRITISH COLUMBIA · Jul 5, 2021
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial called "Self-Management for Amputee Rehabilitation Using Technology" is studying a new online program designed to help people who have had a lower limb amputation. The goal is to provide support and education to help these individuals manage their health and improve their quality of life after their surgery. The program, named SMART, will offer information on how to care for prosthetic limbs, as well as weekly support from peers who understand what they are going through. The trial aims to evaluate how effective this program is for older adults, aged 50 and older, living in British Columbia and Ontario, Canada.
To participate in the trial, individuals must have had a unilateral lower limb amputation due to conditions like diabetes or vascular disease within the last two years. They also need to be able to speak and read English, have access to a computer or tablet, and live in the specified regions. Participants can expect to engage with the SMART program online, where they will receive valuable information and encouragement as they navigate their rehabilitation journey. This trial is important because it may provide a new and accessible way for amputees to manage their recovery, especially in areas where healthcare resources can be limited.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Has a unilateral LLA (transtibial or transfemoral) due to diabetes or vascular disease
- • Received initial casting of their prosthesis within the past 2 years
- • Be aged ≥ 50 years (85% of adults with LLA)
- • Self-identifies as being able to speak and read English.
- • Has access to computer or tablet and internet.
- • Individuals living in British Columbia or Ontario, Canada.
- Exclusion Criteria:
- • Substantial health conditions (e.g., congestive heart failure, diagnosed dementia)
- • Those anticipating further surgery (e.g. LLA revision) as identified by our study sites' physiatrists
- • an inability to use a tablet (e.g. using hands for typing).
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
William C Miller, PhD
Principal Investigator
The University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials